Treace Medical Concepts, Inc.
TMCINASDAQHealthcare● Active
$3.53
+$0.02(+0.57%)
Market Cap$229001605
P/E Ratio—
52W High$7.78
52W Low$1.17
Treace Medical Concepts, Inc. (TMCI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TMCI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.21B | $0.21B | $0.19B | $0.14B | $0.09B |
| Cost of Revenue | $0.04B | $0.04B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.17B | $0.17B | $0.15B | $0.11B | $0.08B |
| Gross Margin %(computed) | 79.81% | 80.37% | 81.20% | 80.60% | 82.11% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| G&A Expenses | $0.06B | $0.06B | $0.05B | $0.03B | $0.02B |
| Total Operating Expenses | $0.22B | $0.22B | $0.20B | $0.15B | $0.09B |
| Operating Income | ($0.05B) | ($0.06B) | ($0.05B) | ($0.03B) | ($0.02B) |
| Operating Margin %(computed) | -25.46% | -26.60% | -27.48% | -24.57% | -17.49% |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.06B) | ($0.06B) | ($0.05B) | ($0.04B) | ($0.02B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.06B) | ($0.06B) | ($0.05B) | ($0.04B) | ($0.02B) |
| Net Margin %(computed) | -27.74% | -26.63% | -26.47% | -30.19% | -21.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.38 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B |
| EBITDA | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) | ($0.02B) |
| EBITDA Margin %(computed) | -20.30% | -20.09% | -20.85% | -25.58% | -16.74% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Treace Medical Concepts, Inc. data
About Treace Medical Concepts, Inc. (TMCI) Income Statement
Treace Medical Concepts, Inc. (TMCI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TMCI reported revenue of $0.21B, gross profit of $0.17B (gross margin 79.81%), and net income of ($0.06B) — a net profit margin of -27.74%.
Frequently asked questions
TMCI · 4 questionsTreace Medical Concepts, Inc. (TMCI) reported revenue of $0.21B for 2025, up 1.6% year-over-year.
TMCI revenueTMCI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08